Figure 4From: Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia Proportions of aparasitaemic (asexual) malaria subject treated with artemisinin-naphthoquine (AN) versus dihydroartemisinin-piperaquine (DHP) groups were significantly difference by Day 0–16 hr (21.8% vs 55.6%, p < 0.0001), Day 1–0 hr (57.5% vs 71.3%, p = 0.01), and Day 1–8 hr (79.8% vs 88.5%, p = 0.03). Back to article page